miR-34a inhibits cancer stemness via targeting CD44 [49]; miR-34a expression inhibits TGF-β-induced EMT and downregulates Snail [50], Slug and ZEB1 as well as the stemness factors (BMI1, CD44, CD133, OLFM4 and c-MYC). Here, CD44 is linked to cancer.